Skip to main content

Market Overview

Pacific Biosciences To Buy DNA Sequencing Firm For Up To $800M, Announces $300M Capital Raise For Deal Funding

Share:
Pacific Biosciences To Buy DNA Sequencing Firm For Up To $800M, Announces $300M Capital Raise For Deal Funding
  • Pacific Biosciences of California Inc (NASDAQ: PACBhas agreed to acquire Omniome, a San Diego-based company developing a short-read sequencing platform. 
  • Under the terms of the agreement, PacBio will acquire Omniome for an upfront payment of $600 million consisting of 9.4 million PacBio shares and $300 million in cash, plus an additional $200 million as milestone payments.
  • PacBio has announced private placement of approximately 11.2 million shares at $26.75 per share in connection with the proposed acquisition, for gross proceeds of roughly $300 million.
  • PacBio also announced preliminary revenue of approximately $30.5 million for Q2 of 2021, representing about 78% Y/Y growth versus a $29.9M estimate.
  • The Company will release full Q2 financial results on August 3.
  • Pacific Biosciences and Invitae Corporation (NYSE: NVTA) announced an intent to expand their multi-year collaboration to develop a production-scale high-throughput HiFi sequencing platform to include the sequencing technology developed by Omniome.
  • Price Action: PACB shares are up 1.03% at $27.51 during the market session on the last check Tuesday.
 

Related Articles (PACB + NVTA)

View Comments and Join the Discussion!

Posted-In: Earnings M&A News Guidance Health Care Financing Offerings Contracts

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com